US Patent Litigations are now available. Check here

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Organic Medicines, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Organic Medicines technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Organic Medicines

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Organic Medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Organic Medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jun 12, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Organic Medicines industry

EP3638243Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 7, 2025MAIWALD
EP3641727Cannabinoid PouchNORDICCANMay 7, 2025NICOVENTURES
EP3801459Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025MAIWALD
EP3971165Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing SameNIPPON SUISAN KAISHAMay 7, 2025KD PHARMA BEXBACH
EP4144230Chilled Pouch Material For Nicotine PouchJTMay 7, 2025NICOVENTURES
EP3781210Treatment Of Sepsis And Septic ShockCOMBIOXINMay 6, 2025BRAND MURRAY FULLER
EP3801459Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 6, 2025SANDOZ
EP4144230Chilled Pouch Material For Nicotine PouchJTMay 6, 2025SWEDISH MATCH NORTH EUROPE
EP3638243Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
EP3923943Genotype And Dose-Dependent Response To An Asbti In Patients With Bile Salt Export Pump DeficiencyMIRUM PHARMACEUTICALSApr 30, 2025GENERICS UK

To stay ahead in the competitive Organic Medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the Organic Medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2959894Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
EP2234617Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
EP3626270Oct 11, 2023New UseNOVARTIS16
EP2962690Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENE15
EP3294283Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
EP2493466Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI MATURE13
EP3246021Nov 13, 2019Apixaban FormulationsPFIZER12
EP3078667Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11